XML 13 R39.htm IDEA: XBRL DOCUMENT v2.4.0.6
Business Combinations (Narrative) (Details) (USD $)
3 Months Ended 12 Months Ended
Apr. 01, 2012
Apr. 03, 2011
Jan. 01, 2012
years
Apr. 01, 2012
2021 Notes [Member]
Nov. 30, 2011
Human Health [Member]
Caliper Life Sciences [Member]
Business Acquisition [Line Items]          
Unsecured senior notes, face value       $ 500,000,000  
Cash paid to the shareholders         646,317,000
Additional contingent consideration 50,800,000        
Deferred revenue acquisition liability         7,825,000
Total transaction costs $ 200,000 $ 2,900,000      
Number of Years in Measurement Period from Acquisition Date to Change Underlying Assumptions     1